PHARMACOLOGICAL TREATMENT, LIFESTYLE MODIFICATION AND AWARENESS IN CORONARY ARTERY AND CEREBROVASCULAR DISEASE PATIENTS

PHARMACOLOGICAL TREATMENT, LIFESTYLE MODIFICATION AND AWARENESS IN CORONARY ARTERY AND CEREBROVASCULAR DISEASE PATIENTS

<p><strong>Abstract </strong></p> <p><strong>INTRODUCTION:</strong><strong> </strong>Cardiovascular diseases (CVD) and cerebrovascular diseases (CeVD) are a large and growing problem in low- and middle-income populations. Secondary prevention, wh...

Full description

Bibliographic Details
Main Authors:	Mojgan Gharipour, Abdolmehdi Baghaei, Katayun Rabiei, Nizal Sarrafzadegan
Format:	Article
Language:	English
Published:	Vesnu Publications 2010-12-01
Series:	ARYA Atherosclerosis
Online Access:	http://arya.mui.ac.ir/index.php/arya/article/view/209

Similar Items

SECONDARY PREVENTION IN CARDIOVASCULAR DISEASES: CLOSING THE GAPS
by: Abdolmehdi Baghaei, et al.
Published: (2010-12-01)

The Pattern of Pharmacological Treatment in Subjects with Metabolic Syndrome: Findings from Isfahan Healthy Heart Program
by: Mojgan Gharipour, et al.
Published: (2011-07-01)

The metabolic syndrome and associated lifestyle factors among the Iranian population
by: Mojgan Gharipour, et al.
Published: (2015-01-01)

The impact of obesity on hypertension and diabetes control following healthy Lifestyle Intervention Program in a developing country setting
by: Aliakbar Tavassoli, et al.
Published: (2011-01-01)

Metabolic Syndrome in Iranian Youths: A Population-Based Study on Junior and High Schools Students in Rural and Urban Areas
by: Alireza Ahmadi, et al.
Published: (2013-01-01)

The impact of a 6-year comprehensive community trial on the awareness, treatment and control rates of hypertension in Iran: experiences from the Isfahan healthy heart program
by: Tavassoli Aliakbar, et al.
Published: (2010-12-01)

Factors Predicting Adherence to Lifestyle Modification among Patients with Coronary Artery Disease
by: Esa, NM, et al.
Published: (2020)

Arterial stiffness and lifestyle modification
by: Asako Miyaki, et al.
Published: (2012-09-01)

COMPARISON OF RETROGRADE VERSUS ANTROGRADE-RETROGRADE COLD BLOOD CARDIOPLEGIA: A RANDOMIZED CLINICAL TRIAL IN PATIENTS WITH CORONARY ARTERY BYPASS GRAFTING
by: Hamid Bigdelian, et al.
Published: (2010-12-01)

Association between Adipokine and Myeloperoxidase Levels in Patients with Coronary Artery Disease
by: Gholam Basati, et al.
Published: (2015-01-01)

Association between dietary salt intake and reservation of renal function in patients with mild hypertension
by: Arsalan Khaledifar, et al.
Published: (2015-04-01)

Analysis of the current recommendations for pharmacologic interventions and lifestyle modifications for treatment of polycystic ovarian syndrome
by: Haserot, Kristen M.
Published: (2021)

Does significant weight reduction in men with coronary artery disease manage risk factors after cardiac rehabilitation program?
by: Masoumeh Sadeghi, et al.
Published: (2013-01-01)

Dual aortic aneurysms with coronary artery and multiple cerebrovascular stenoses
by: Masafumi Hashimoto, et al.
Published: (2021-05-01)

The sustainability of interventions of a community-based trial on children and adolescents’ healthy lifestyle
by: Nizal Sarrafzadegan, et al.
Published: (2014-04-01)

How Are Epigenetic Modifications Related to Cardiovascular Disease in Older Adults?
by: Mojgan Gharipour, et al.
Published: (2021-09-01)

The Effect of Parental Medical History on the Prevalence of Cerebrovascular Diseases in Their Children in an Iranian Population
by: Alireza Khosravi, et al.
Published: (2018-09-01)

Assessing Metabolic Syndrome Through Increased Heart Rate During Exercise
by: Masoumeh Sadeghi, et al.
Published: (2016-12-01)

Differences in the prevalence of metabolic syndrome in boys and girls based on various definitions
by: Nizal Sarrafzadegan, et al.
Published: (2013-03-01)

Socioeconomic characteristics and controlled hypertension: Evidence from Isfahan Healthy Heart Program
by: Mojgan Gharipour, et al.
Published: (2013-03-01)

Association between adolescence obesity and metabolic syndrome: Evidence from Isfahan Healthy Heart Program
by: Alireza Ahmadi, et al.
Published: (2014-01-01)

Metabolic syndrome in Iranian elderly
by: Nizal Sarrafzadegan, et al.
Published: (2012-01-01)

NE-nu-SVC: A New Nested Ensemble Clinical Decision Support System for Effective Diagnosis of Coronary Artery Disease
by: Moloud Abdar, et al.
Published: (2019-01-01)

Preconditioning by isoflurane as a volatile anesthetic in elective coronary artery bypass surgery
by: Amjad Kiani, et al.
Published: (2013-05-01)

Modificación de conocimientos y estilos de vida en adultos mayores con enfermedad cerebrovascular Modification to knowledge and lifestyles in older adults with cerebrovascular diseases
by: Leidys Proenza Fernández, et al.
Published: (2012-10-01)

Elevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery disease FNx01
by: Saedziaaldin Samsamshariat, et al.
Published: (2011-01-01)

Off pump coronary artery bypass grafting in a patient with cerebrovascular disease
by: S K S Rawat, et al.
Published: (2015-01-01)

Evaluating the Relationship between Rheumatic Valvular Heart Disease ‌and Coronary Artery Diseases in Patient with Stable Angina in Isfahan City, Iran
by: Faezeh Farhang, et al.
Published: (2018-01-01)

Effect of age on the phenotype of metabolic syndrome in developing country
by: Mojgan Gharipour, et al.
Published: (2015-01-01)

The Impacts of Cardiac Rehabilitation Program on Echocardiographic Parameters in Coronary Artery Disease Patients with Left Ventricular Dysfunction
by: Masoumeh Sadeghi, et al.
Published: (2013-01-01)

Reduced plasma adiponectin levels relative to oxidized low density lipoprotein and nitric oxide in coronary artery disease patients
by: Gholam Basati, et al.
Published: (2011-01-01)

Impact of prior cerebrovascular events on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or percutaneous coronary intervention
by: Yu Pan, et al.
Published: (2021-08-01)

Drugs and lifestyle for the treatment and prevention of coronary artery disease: comparative analysis of the scientific basis
by: P.L. da Luz, et al.
Published: (2011-10-01)

Drugs and lifestyle for the treatment and prevention of coronary artery disease: comparative analysis of the scientific basis
by: P.L. da Luz, et al.
Published: (2011-10-01)

Predictive value of P-wave duration and dispersion in post coronary artery bypass surgery atrial fibrillation
by: Mohammad Hashemi Jazi, et al.
Published: (2012-06-01)

Impaired cerebrovascular function in coronary artery disease patients and recovery following cardiac rehabilitation.
by: Udunna C Anazodo, et al.
Published: (2016-01-01)

IS THERE ANY DIFFERENCE BETWEEN DIETARY HABITS IN HYPER-TENSIVES, HYPERLIPIDEMICS, OBESE, SMOKER INDIVIDUALS AND THE NORMAL POPULATION?
by: Javed Hussain Akhtar, et al.
Published: (2010-12-01)

Anthropometric indices predicting incident hypertension in an Iranian population: The Isfahan cohort study
by: Masoumeh Sadeghi, et al.
Published: (2019-06-01)

The Cut-Off Values of Anthropometric Indices for Identifying Subjects at Risk for Metabolic Syndrome in Iranian Elderly Men
by: Mojgan Gharipour, et al.
Published: (2014-01-01)

Is there any relationship between different phenotypes of metabolic syndrome and cardiovascular mortality rate?
by: Alireza Khosravi, et al.
Published: (2016-01-01)

Cannot write session to /tmp/vufind_sessions/sess_v99c7h0pbf02isnghrl6g1i5l7